These drugs work by making you eat less. Eating less means taking in less of everything, not only calories. That is obvious once stated and almost nobody states it.
What the review found
A structured search of PubMed and the Cochrane Database covering January 2019 to May 2025 turned up six adult studies with nutritional endpoints, together covering 480,825 people. [1] Vitamin D deficiency was the most common abnormality, in 7.5% of users at six months and 13.6% at twelve. Iron depletion was frequent: ferritin ran 26% to 30% lower than in a comparison group taking SGLT2 inhibitors — a different diabetes drug, not an untreated control.
Intake was worse than status. More than 60% of users were eating below estimated requirements for calcium and for iron. Vitamin D intake averaged about a fifth of the recommended amount. Thiamine and B12 deficits grew over time, and protein and calcium shortfalls contributed to loss of lean mass — the same problem measured directly elsewhere.
Why it goes unnoticed
The early symptoms are the symptoms of everything. Tiredness. Feeling cold. Thinning hair. Getting out of breath on stairs. A person who has lost twenty pounds attributes all of that to the diet, and so does everybody around them.
Nausea makes it worse by narrowing what people can face eating, which tends to mean less meat, less dairy and fewer vegetables. That is a predictable consequence of the titration period and nobody schedules a blood test around it.
What would actually catch it
A blood test. Vitamin D, ferritin, B12 and a basic metabolic panel cover most of what the review flags, and they are cheap and ordinary. The review’s own recommendation is targeted nutritional assessment and individualized laboratory evaluation for people at higher risk of malnutrition — a clinician deciding what to measure, rather than a reader buying supplements on the strength of a percentage.
Who is at higher risk is not mysterious: people losing weight fast, people who were already eating poorly, people with a restricted diet, and people who have had bariatric surgery. That last group is already monitored for exactly this, which is worth remembering — the medical system has a protocol for rapid weight loss and nutrition, and it exists on the surgical side of the market.
What sellers say about it
Close to nothing. A prescription arrives, a titration schedule arrives, and no seller on this roster publishes a monitoring plan or suggests a baseline panel. That absence is not unique to nutrition — it runs across almost every clinical question this market touches, and the census counts how wide the silence runs.
There is no accusation in that. A telehealth seller is not set up to run longitudinal labs, and most of them do not pretend to be. The point is that the gap is yours to close. If you are buying a year of a drug that reduces how much you eat, ask a clinician what to measure and when — before the tiredness starts and gets attributed to the diet.